Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy

Medicine and Dentistry

• Drug Therapy 100%
• Gastrointestinal Stromal Tumor 100%
• Neoplasm 50%
• Surgery 50%
• Disease Free Survival 50%
• Imatinib 50%
• Mitosis Rate 33%
• Disease 16%
• Metastatic Carcinoma 16%
• Multivariate Analysis 16%
• Tumor Recurrence 16%
• Recurrent Disease 16%
• Adverse Outcome 16%
• Tertiary Care 16%
• Disease Specific Survival 16%
• Prognostic Factor 16%
• Peritoneum 16%
• Recurrence Risk 16%

Keyphrases

• Targeted Drug Therapy 100%
• Surgical Outcomes 100%
• Imatinib Mesylate 50%
• Surgically Treated 33%
• Disease-free Survival 33%
• Mitotic Rate 16%
• Multiorgan Resection 16%
• KIT mutation 16%
• Surgical Treatment 16%
• Primary Disease 16%
• Long-term Disease-free Survival 16%
• Peritoneum 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease Free Survival 50%